Challenging differential diagnosis Background:
Background
Oxidative stress can be defined as an imbalance between the pro-oxidant and the antioxidant potential of cells, which results either from an overproduction of reactive oxygen species (ROS), insufficient detoxification of ROS by antioxidants, or a combination of both [1] . It is widely known that ROS function as key metabolites that can impair biological processes, resulting in various diseases, including cardiovascular disease, diabetes mellitus, neurological disorders, and cancer [2] [3] [4] .
In lung transplantation, severe oxidative stress is expected when ischemia/reperfusion injury, acute allograft rejection, and various infections occur, and these are the major obstacles to long-term survival. Currently, blood levels of hydroperoxides, a type of ROS, can be easily and accurately measured in patients as an index of oxidative injury to cellular components. In addition, plasma ferric-reducing ability can be assessed as an index of total antioxidant potential. Both hydroperoxides and ferric-reducing capacity can be measured with a small volume of patients' blood using a Free Radical Elective Evaluator [4] (FREE ® Carpe Diem; Wismerll Co. Ltd., Tokyo, Japan).
However, there have been few clinical reports about the oxidative stress response with lung transplantation. We hypothesized that the measurement of oxidative stress could help anticipate infections or allograft rejections and distinguish them correctly. Two cases of the serial measurement of the oxidative stress response after lung transplantation, which could become a useful tool to identify infection, are reported.
Case Report Case 1
A 30-year-old Japanese man underwent right single lung transplantation for chronic obstructive pulmonary disease. He had been receiving a standard triple immunosuppressant regimen: tacrolimus (target trough level, 15-20 ng/mL for the first 3 months, followed by 10-15 ng/mL), MMF (1500 mg/day), and prednisolone (0.4 mg/kg/day for the first 6 months, followed by 0.2 mg/kg/ day). The prophylactic strategies for fungal and viral infections were oral voriconazole at 400 mg/day, trimethoprim-sulfamethoxazole at 1 g every other day, and valganciclovir at 900 mg/day.
He developed ischemic change of the bronchial anastomosis after transplantation, resulting in bronchial stenosis. This made it difficult for him to expectorate sputum, so frequent bronchoscopic airway cleaning was needed. Infectious episodes were successfully treated by intravenous antibiotics, but the bronchial stenosis worsened gradually ( Figure 1 ). Therefore, a Y-shaped airway silicone stent was inserted 5 months after transplantation. Fortunately, his condition after airway stent insertion improved, and he was discharged without any symptoms after 6 months of hospitalization. No allograft rejection was seen during this period.
Oxidative stress in this patient was monitored constantly (total 55 times) using a Free Radical Elective Evaluator after transplantation. This study was conducted in accordance with the principles of the Helsinki Declaration and local ethics committee approval for this clinical research was obtained prior to its commencement. The measurement points were determined by the times for routine blood collection in our lung transplant protocol and when clinical symptoms appeared. Briefly, the levels of blood hydroperoxides, called diacron-reactive oxygen metabolites (d-ROMs), a type of ROS, were measured as an index of oxidative injury, and the biological antioxidant activity of plasma (BAP) was also measured. The d-ROMs are expressed in arbitrary units called Carratelli units (U.CARR). The normal values of both d-ROM and BAP were determined as shown in Table 1 . The principles and methods of this apparatus have been previously described [4] .
The d-ROM levels were significantly (p<0.01) higher during treatment of infection (n=23, 401 U.CARR) than during non-treatment conditions (n=32, 277 U. CARR). On the other hand, the BAP levels were not significantly different (p=0.63, 2960 µmol/L, 2880 µmol/L, respectively). The d-ROM level after airway silicone stent insertion improved to the non-treatment level ( Figure 2 ).
Case 2
A 44-year-old Japanese woman underwent right single lung transplantation for lymphangioleiomyomatosis. She had been receiving a standard triple immunosuppressant regimen and infectious prophylactic strategies as per our lung transplant protocol described in Case 1. Her postoperative clinical course was uneventful, and no allograft rejection and no infections were seen. The d-ROM and BAP levels were measured as per the protocol for Case 1, and both levels measured during this period (15 times) remained almost within the normal range ( Figure 3 ).
Discussion
This report describes 2 clinical cases of the serial measurement of the oxidative stress response after lung transplantation. We found that high oxidative stress occurred during infections, and the serial measurement of oxidative stress could be a useful tool to identify infectious conditions. In lung transplantation, severe oxidative stress is expected when ischemia/reperfusion injury, acute allograft rejection, and various infections occur. These conditions also contribute to the development of bronchiolitis obliterans syndrome (BOS), which prevents long-term survival [5] .
There have been several reports [6] [7] [8] [9] [10] about oxidative stress in transplant patients by measurements of various kinds of markers, such as lipid peroxidation, oxidized glutathione, and malondialdehyde. Hussein et al. [7] reported that the severity of oxidative stress in pediatric liver transplant patients was correlated with their laboratory data. In addition, malondialdehyde was reported as an early predictive marker of graft Middle stress 341-400 Strong reduction 1600-1400
High stress 401-500 Very strong reduction >1400
Very high >501 dysfunction in kidney transplantation [9] . These reports indicated that the measurement of oxidative stress could enable us to identify the onset and development of many kinds of incidents after transplantation.
Currently, blood levels of hydroperoxides, a type of ROS, can be easily and accurately measured as diacron-reactive oxygen metabolites (d-ROMs). In addition, plasma ferric-reducing ability can be assessed as an index of total antioxidant potential, called the biological antioxidant activity of plasma (BAP). We have previously reported that video-assisted thoracic surgery attenuates perioperative d-ROMs compared to thoracotomy in lung cancer patients [4] . In addition, d-ROM could be a useful index of disease severity, not only for transplant patients, but also for patients with chronic obstructive pulmonary disease [11] and bronchial asthma [12] . However, to date, no clinical evidence has shown the effectiveness of d-ROM and BAP levels in lung transplant patients.
In Case 1, d-ROM levels were significantly (p<0.01) higher during treatment of infection (n=23, 401 CARR) than during nontreatment conditions (n=32, 277 CARR). In contrast, in Case 2, no significant d-ROM level fluctuation was seen under stable conditions. This shows that infectious episodes apparently lead to activation of inflammatory mediators, resulting in increased production of ROS, as Madill reported [5] . Moreover, it is interesting that d-ROM levels decreased to non-treatment levels after infection treatment and after airway silicone stent insertion.
The measurement of d-ROM and BAP is a non-invasive tool; however, the frequency in our study could have been reduced, especially for stable patients.
We cannot reach a firm conclusion about this problem in infection and rejection cases because there are no reports in the literature on the frequency of measurements of d-ROM and BAP.
According to the International Heart and Lung Transplantation Registry [13] , within the first year post-transplantation, infections contribute to early mortality. Thus, it is desirable for clinicians to correctly and promptly distinguish and diagnose infections from allograft rejection and treat them. Given the present results, serial measurement of d-ROMs could be an effective tool to identify and monitor the effect of treatment for infections, similar to the ImmuKnow assay reported previously [14] .
Several limitations must be considered when interpreting the present findings: only 2 cases were reported, and follow-up was limited to the hospitalization period. Therefore, further accumulation of clinical cases and follow-up is needed to determine the effectiveness of measurement oxidative stress in lung transplant patients.
Conclusions
We reported 2 clinical cases of the serial measurement of the oxidative stress response after lung transplantation, which might become a non-invasive marker of complications after transplantation.
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